Wolfe Research Starts Zymeworks (ZYME) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Price: $27.69 +2.90%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Join SI Premium – FREE
Wolfe Research analyst Kalpit Patel initiates coverage on Zymeworks (NASDAQ: ZYME) with a Outperform rating.
For an analyst ratings summary and ratings history on Zymeworks click here. For more ratings news on Zymeworks click here.
Shares of Zymeworks closed at $26.24 yesterday.
You May Also Be Interested In
- Guggenheim Starts Kazia Therapeutics (KZIA) at Buy
- Citi Starts Shenzhen Longsys Electronics (301308:CH) at Buy
- Nomura/Instinet Starts NTPC Green Energy (NTPCGREE:IN) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
